GLUE icon

Monte Rosa Therapeutics
GLUE

Overview Fund Trends Analyst Outlook Journalist POV

48 hedge funds and large institutions have $705M invested in Monte Rosa Therapeutics in 2021 Q2 according to their latest regulatory filings, with 48 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
48
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$175M
2
+$93.5M
3
+$69.6M
4
ACA
Avoro Capital Advisors
New York
+$62.2M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$61.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$175M
2
$93.5M
3
$69.5M
4
$62.2M
5
$61.3M
6
$35.2M
7
$33.4M
8
$33.2M
9
$25.2M
10
$21.8M
11
$7.95M
12
$7.95M
13
$6.81M
14
$6.81M
15
$6.81M
16
$5.4M
17
$5.34M
18
$4.72M
19
$3.4M
20
$3.16M
21
$2.94M
22
$2.72M
23
$2.72M
24
$2.46M
25
$2.36M
1
2